Gideon Stein

Gideon Stein has a diverse work experience spanning various roles in the medical and pharmaceutical industries. Gideon began their career as a physician in Otolaryngology head and neck surgery at Meir Hospital in 1997 and continued in that role until 2013. In 2003, they joined BioLineRx as the Director of Business Development and later became the Executive Director of Innovative Ventures. In 2018, they took on the role of Senior Director of Clinical Development Strategy at BioLineRx. In 2012, Stein co-founded PROJOINT LTD, a clinical-stage company focused on developing medical devices for osteoarthritis in humans and veterinary practices. Gideon served as the CEO of PROJOINT LTD until 2018. In 2015, they co-founded Wize Pharma Inc, where they worked as a medical consultant until 2020. Most recently, in 2023, Stein co-founded Resmetrix Medical Ltd and assumed the position of CEO. Resmetrix is a medical technology company focused on wireless pulmonary function sensors and cloud-based disease management systems.

Gideon Stein holds multiple degrees, including an MD, MHA, and MBA, from Tel Aviv University. No information is available regarding the start and end year or the specific field of study for their education.